Cell and Gene Therapy

Cell and gene therapy has never been more exciting, with rapid advances driving the field from research to clinical practice. Innovations such as CAR-NK therapies, next-generation CAR constructs, and the discovery of novel target antigens continue to expand clinical applications and commercial opportunities. However, manufacturing and commercializing cell therapies have never been more challenging. New, updated guidelines and regulations are constantly evolving to catch up with the discovery and implementation of impactful, innovative cell and gene therapies. Helping our partners navigate and advance their cell and gene therapies has always been a cornerstone in ACROBiosystems, starting from the very first recombinant antigen sold from us. With our products and reagents, we strive to provide the highest quality products possible, tailored for your cell and gene therapy needs and applications.